Health
Immunomodulatory drugs improve the success rate of cancer therapies – News-Medical.Net
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such…
Immunomodulatory drugs, including the Contergan derivatives lenalidomide and pomalidomide, have significantly improved the therapy of hematologic malignancies such as multiple myeloma.
Researchers at the Technical University of Munich (TUM) have now further decoded the mode of action in this class of medications. At the same time, they identified new innovative targeted cancer therapies.
The drug thalidomide was sold as a sedative under the trade name Contergan in the 1950s and 1960s. At the time,…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Business6 hours agoFord CEO makes stunning prediction about artificial intelligence